Learn More
OBJECTIVE Reactive oxygen species have been implicated in the pathogenesis of inflammatory and vascular disease. We have undertaken a controlled trial to evaluate probucol, a synthetic antioxidant, as a potential therapy for Raynaud's phenomenon. METHODS The study cohort included patients with systemic sclerosis (SSc; n = 20), primary Raynaud's phenomenon(More)
  • 1